Anodyne| 5-HO-DMT | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Conformer [] | |
|---|---|
| Physical properties [] | |
|---|---|
| Molecular mass | 204.27 g/mol [1] |
| Melting point | 146.5 °C [1] |
| Predicted LogP | 1.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H16N2O [1] |
| IUPAC name | 3-[2-(dimethylamino)ethyl]-1H-indol-5-ol [1] |
| SMILES | CN(C)CCC1=CNC2=C1C=C(C=C2)O [1] |
| InChI | InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 [1] |
| InChIKey | VTTONGPRPXSUTJ-UHFFFAOYSA-N [1] |
| Dosing [] | |
|---|---|
| Duration of action | Oral administration: ~2 hours Intranasal administration: 30–90 min Sublingual administration: 30–90 min Rectal administration: ~1 hour Inhalational administration: 60–90 min Intravenous injection: ~5–120 min |
Bufotenin
Bufotenin (also known as Bufotenine, 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol, N,N-Dimethyl-5-HT, 5-OH-DMT, 3-(2-(Dimethylamino)ethyl)-1H-indol-5-ol, 3-(2-dimethylaminoethyl)-1H-indol-5-ol, 5-22-12-00026, 1,5-benzoxazepin-4(5H)-one, 2,3-dihydro-8-methoxy-2,2,5,6-tetramethyl-, 8-methoxy-2,2,5,6-tetramethyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one or 3-(b-(Dimethylamino)ethyl)-5-hydroxyindole) is a psychedelic substance of the tryptamine class.
Chemistry
Stereochemistry []
Bufotenin is a achiral mixture
Legal status
- Australia: Bufotenin is a S9 substance.
- Canada: Bufotenin is a Unscheduled substance.
- Germany: Bufotenin is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Bufotenin is a Class A substance.
- United States: Bufotenin is a Schedule I substance.